Haleon (HLN) Long-Term Deferred Tax (2021 - 2025)
Haleon (HLN) posted Long-Term Deferred Tax of $384.4 million for Q4 2025, up 8.52% on a QoQ basis from $354.2 million in Q4 2024, and up 8.52% year-over-year from $354.2 million in Q4 2024.
Haleon (HLN) Long-Term Deferred Tax (2021 - 2025) Analysis & Trends
Haleon's Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $384.4 million for Q4 2025.
- Quarterly Long-Term Deferred Tax rose 8.52% year-over-year to $384.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $384.4 million (up 8.52% YoY) and the FY2025 annual result came in at $381.0 million, up 8.01% from the prior year.
- Long-Term Deferred Tax was $384.4 million for Q4 2025 at Haleon, up from $354.2 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $420.6 million in Q4 2021 and bottomed at $255.6 million in Q2 2022.
- A 5-year average of $329.6 million and a median of $331.1 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax sank 38.65% — and 2023, when it increased 27.46%.
- Haleon's Long-Term Deferred Tax stood at $420.6 million in 2021, then sank by 38.65% to $258.0 million in 2022, then gained by 27.46% to $328.9 million in 2023, then climbed by 7.7% to $354.2 million in 2024, then rose by 8.52% to $384.4 million in 2025.
- Business Quant data shows HLN's Long-Term Deferred Tax at $384.4 million in Q4 2025, $354.2 million in Q4 2024, and $333.2 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 384.42 Mn |
| Dec 31, 2024 | 354.25 Mn |
| Jun 30, 2024 | 333.23 Mn |
| Dec 31, 2023 | 328.91 Mn |
| Jun 30, 2023 | 301.58 Mn |
| Dec 31, 2022 | 258.04 Mn |
| Jun 30, 2022 | 255.64 Mn |
| Dec 31, 2021 | 420.58 Mn |